Dimensional Fund Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.59M Buy
623,084
+9,112
+1% +$96.4K ﹤0.01% 2437
2025
Q1
$9.23M Sell
613,972
-43,383
-7% -$652K ﹤0.01% 2283
2024
Q4
$10.8M Sell
657,355
-50,011
-7% -$823K ﹤0.01% 2276
2024
Q3
$17.5M Sell
707,366
-41,918
-6% -$1.04M ﹤0.01% 2066
2024
Q2
$19M Sell
749,284
-60,471
-7% -$1.53M 0.01% 1979
2024
Q1
$20.6M Sell
809,755
-11,697
-1% -$297K 0.01% 1970
2023
Q4
$18.6M Sell
821,452
-38,683
-4% -$877K 0.01% 2023
2023
Q3
$16M Sell
860,135
-117,727
-12% -$2.19M 0.01% 2039
2023
Q2
$25.4M Sell
977,862
-438
-0% -$11.4K 0.01% 1805
2023
Q1
$28.1M Buy
978,300
+18,554
+2% +$533K 0.01% 1729
2022
Q4
$28.4K Buy
959,746
+19,944
+2% +$590 0.01% 1679
2022
Q3
$22.4M Buy
939,802
+38,915
+4% +$926K 0.01% 1758
2022
Q2
$20.1M Buy
900,887
+30,588
+4% +$683K 0.01% 1863
2022
Q1
$21.9M Buy
870,299
+14,175
+2% +$356K 0.01% 1922
2021
Q4
$30.7M Sell
856,124
-5,809
-0.7% -$208K 0.01% 1744
2021
Q3
$36.7M Buy
861,933
+8,213
+1% +$350K 0.01% 1642
2021
Q2
$37M Sell
853,720
-6,834
-0.8% -$296K 0.01% 1680
2021
Q1
$35.2M Sell
860,554
-23,562
-3% -$963K 0.01% 1705
2020
Q4
$40M Sell
884,116
-37,464
-4% -$1.7M 0.01% 1551
2020
Q3
$32.6M Sell
921,580
-9,752
-1% -$345K 0.01% 1537
2020
Q2
$35.1M Sell
931,332
-10,901
-1% -$411K 0.02% 1495
2020
Q1
$27.2M Sell
942,233
-59,061
-6% -$1.71M 0.01% 1542
2019
Q4
$51.9M Sell
1,001,294
-43,697
-4% -$2.27M 0.02% 1388
2019
Q3
$57.4M Sell
1,044,991
-4,314
-0.4% -$237K 0.02% 1266
2019
Q2
$42.6M Buy
1,049,305
+25,126
+2% +$1.02M 0.02% 1571
2019
Q1
$31M Buy
1,024,179
+26,738
+3% +$809K 0.01% 1802
2018
Q4
$33.5M Sell
997,441
-44
-0% -$1.48K 0.02% 1640
2018
Q3
$42.1M Buy
997,485
+19,916
+2% +$840K 0.02% 1634
2018
Q2
$31.3M Buy
977,569
+46,798
+5% +$1.5M 0.01% 1846
2018
Q1
$46.3M Buy
930,771
+29,467
+3% +$1.47M 0.02% 1431
2017
Q4
$48.6M Buy
901,304
+5,704
+0.6% +$308K 0.02% 1379
2017
Q3
$51.9M Buy
895,600
+17,594
+2% +$1.02M 0.02% 1264
2017
Q2
$43.3M Buy
878,006
+106,307
+14% +$5.25M 0.02% 1400
2017
Q1
$33.5M Buy
771,699
+40,020
+5% +$1.74M 0.02% 1595
2016
Q4
$35.8M Buy
731,679
+1,755
+0.2% +$85.9K 0.02% 1489
2016
Q3
$34.9M Sell
729,924
-18,159
-2% -$869K 0.02% 1435
2016
Q2
$40.1M Sell
748,083
-33,113
-4% -$1.78M 0.02% 1204
2016
Q1
$34.9M Buy
781,196
+6,171
+0.8% +$276K 0.02% 1316
2015
Q4
$29.6M Buy
775,025
+41,155
+6% +$1.57M 0.02% 1414
2015
Q3
$23.4M Buy
733,870
+14,809
+2% +$471K 0.02% 1581
2015
Q2
$23.8M Buy
719,061
+7,836
+1% +$259K 0.01% 1667
2015
Q1
$29.3M Sell
711,225
-91,843
-11% -$3.78M 0.02% 1406
2014
Q4
$32.7M Sell
803,068
-145,864
-15% -$5.94M 0.02% 1207
2014
Q3
$34.8M Sell
948,932
-2,198
-0.2% -$80.6K 0.02% 1009
2014
Q2
$44.1M Buy
951,130
+20,644
+2% +$956K 0.03% 823
2014
Q1
$38.2M Buy
930,486
+13,808
+2% +$567K 0.03% 873
2013
Q4
$35M Buy
916,678
+37,864
+4% +$1.44M 0.03% 917
2013
Q3
$21.1M Buy
878,814
+40,102
+5% +$961K 0.02% 1362
2013
Q2
$14.3M Buy
+838,712
New +$14.3M 0.01% 1661